Pharmaceuticals by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceuticals ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- AED 18.67T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | AED 35.1B | AED 232.32 | 0.88% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | AED 29.7B | AED 427.96 | 0.07% down | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | AED 17.8B | AED 316.28 | 0.99% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | AED 29.8B | AED 457.19 | 0.14% down | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | AED 31.3B | AED 1,120.50 | 0.01% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | AED 26.4B | AED 189.67 | 0.01% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | AED 16.6B | AED 99.38 | 0.37% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | AED 21.7B | AED 1,082.36 | 0.31% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | AED 32.9B | AED 346.00 | 0.43% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | AED 28.6B | AED 169.96 | 1.83% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | AED 16.4B | AED 149.56 | 3.13% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | AED 55.3B | AED 283.63 | 0.56% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | AED 16.9B | AED 48.26 | 5.40% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | AED 18B | AED 103.69 | 1.38% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | AED 21.8B | AED 334.64 | 0.90% down | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | AED 17.6B | AED 183.26 | 2.35% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | AED 24B | AED 354.07 | 0.09% up | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | AED 18.5B | AED 221.23 | 0.20% down | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | AED 35.3B | AED 1,518.49 | 2.02% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | AED 57.2B | AED 891.17 | 0.81% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | AED 27.1B | AED 247.54 | 3.81% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | AED 22.3B | AED 158.01 | 0.08% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | AED 19.1B | AED 453.37 | 1.74% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | AED 42.5B | AED 219.21 | 2.02% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | AED 14.3B | AED 104.81 | 2.86% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | AED 48.2B | AED 96.48 | 1.62% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | AED 96.1B | AED 437.87 | 2.16% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | AED 102.8B | AED 141.81 | 0.25% down | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | AED 25.6B | AED 486.28 | 2.60% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | AED 11.4B | AED 58.94 | 0.37% down | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | AED 27.6B | AED 350.72 | 0.41% up | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | AED 31B | AED 38.71 | 1.22% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | AED 26.9B | AED 306.85 | 1.77% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | AED 65B | AED 991.69 | 0.43% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | AED 89.2B | AED 2,093.42 | 2.41% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | AED 124.9B | AED 307.28 | 0.23% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | AED 75.3B | AED 562.02 | 2.21% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | AED 23.7B | AED 582.51 | 0.57% up | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | AED 27.4B | AED 78.78 | 1.56% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | AED 86.6B | AED 75.56 | 0.61% up | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | AED 45.8B | AED 54.89 | 1.05% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | AED 181.1B | AED 155.20 | 0.84% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | AED 589.2B | AED 103.36 | 1.14% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | AED 449.1B | AED 219.73 | 2.48% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | AED 144.3B | AED 250.98 | 0.50% down | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | AED 362.8B | AED 3,506.98 | 0.30% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | AED 496.4B | AED 1,957.81 | 0.21% down | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | AED 116.1B | AED 188.25 | 1.35% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | AED 169.3B | AED 1,481.87 | 2.36% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | AED 662.6B | AED 382.60 | 0.51% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | AED 1.26T | AED 513.08 | 2.55% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | AED 1.87T | AED 1,055.51 | 1.85% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | AED 21.3B | AED 31.25 | 1.39% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | AED 639.3B | AED 145.06 | 2.95% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | AED 4.56T | AED 5,116.60 | 1.58% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | AED 359.5B | AED 179.36 | 0.81% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | AED 2.43T | AED 1,009.97 | 1.32% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | AED 417B | AED 173.67 | 0.50% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | AED 1.08T | AED 574.31 | 1.73% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | AED 1.02T | AED 656.79 | 1.88% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | AED 250.8B | AED 78.50 | 1.22% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6725 AED).
Questions and answers
Which pharmaceuticals rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceuticals ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceuticals are in this ranking?
61 are ranked by short interest.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by short interest have a combined market value of AED 18.67T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceuticals by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.